撒哈拉以南非洲7家癌症治疗中心的神经外科肿瘤治疗经验:面临的挑战与障碍
该研究于2023年4月通过REDCap向撒哈拉以南非洲7国7家转诊医院的神经外科医生发放42项自填问卷,收集国家及医院层面的神经外科肿瘤治疗能力数据。结果显示6国仅有限省份可提供神经外科肿瘤治疗,7国神经外科人力密度0.03-0.67/10万人,儿科0-0.05/10万人,无中心具备专科神经肿瘤、神经重症、神经放射或神经病理 expertise。作者结论认为该地区特别是儿童神经外科肿瘤治疗面临重大挑战,需系统层面干预。
要点
- 7国中6国神经外科肿瘤治疗仅覆盖有限省份,人力密度0.03-0.67/10万人
- 2家中心无儿科ICU,5家儿科ICU床位1-8张;1家医院无CT和MRI
- 无医院提供专科神经肿瘤治疗或儿科神经肿瘤医生,3家无辅助化疗或放疗
核心结论
- 撒哈拉以南非洲在及时、高质量的神经外科肿瘤治疗方面存在重大挑战,儿童尤为突出。
- 需要系统层面的干预来加强撒哈拉以南非洲的神经外科肿瘤治疗能力。
研究设计与样本
- 2023年4月,通过REDCap向撒哈拉以南非洲7国7家国家转诊医院的合作神经外科医生发放42项自填问卷,收集国家和医院层面的神经外科肿瘤治疗能力数据。
主要发现
- 7国中6国的神经外科和神经外科肿瘤治疗仅在有限的省、州、地区或县提供。
- 7国普通神经外科人力密度为0.03至0.67/10万人,儿科神经外科人力密度为0至0.05/10万人。
- 2家中心无儿科ICU,其余5家儿科ICU床位数为1至8张;1家医院无CT和MRI,仅依赖私营诊断机构进行神经影像检查。
- 组织病理服务主要限于基本组织病理染色,分子分型仅1家中心可提供;3家医院提供儿科麻醉专长。
- 无医院提供专科神经肿瘤治疗或拥有儿科神经肿瘤医生;7家医院均无正式神经重症监护、神经放射学或神经病理学专长;3家中心无辅助化疗或放疗;所有7家中心康复主要限于基本物理和职业治疗。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Wide disparities in neurosurgical oncology care and treatment outcomes exist globally despite recent improvements in diagnostics and cancer therapy. To better understand the challenges to neurosurgical oncology care in low-resource settings, the authors collected data on national neurosurgical capacity and hospital diagnostic and treatment capacity across 7 national referral hospitals in 7 countries in sub-Saharan Africa (SSA). METHODS: In April 2023, a 42-item self-administered questionnaire was distributed to partner neurosurgeons at the 7 centers via REDCap to provide country- and hospital-level capacity data on neurosurgical oncology care. RESULTS: Neurosurgical and neurosurgical oncology care were reported to be available in a limited number of provinces, states, regions, and counties in 6 of the 7 countries. The general neurosurgical workforce density across the 7 countries ranged from 0.03 to 0.67 per 100,000 persons, and that of the pediatric neurosurgical workforce ranged from 0 to 0.05 per 100,000 persons. Two centers had no pediatric ICUs, and the remaining 5 centers had pediatric ICUs with bed capacities between 1 and 8. One hospital had neither a CT nor an MRI scanner available and relied solely on private diagnostic facilities for neuroimaging. Histopathology services were largely limited to basic histopathology staining only; molecular subtyping was available at a single center. Three hospitals offered pediatric anesthesia expertise. None of the hospitals offered subspecialty neuro-oncology care or had a pediatric neuro-oncologist. None of the 7 hospitals had formal neurocritical care, neuroradiology, or neuropathology expertise. Neither adjuvant chemotherapy nor radiotherapy was available at 3 centers. Rehabilitation was largely limited to basic physical and occupational therapy at all 7 centers. Although all 7 countries had a multiple health payer system, the payment structure differed across the 7 hospitals for different neurosurgical oncology services, with patients making out-of-pocket payments for all services in some cases. CONCLUSIONS: There are significant challenges to timely and quality neurosurgical oncology care in SSA especially for children. System-level interventions are needed to strengthen neurosurgical oncology care capacity in SSA.
引用
- Ashagere Y, Shabani HK, Labuschagne J, et al. Sub-Saharan African experience of neurosurgical oncology care: challenges and barriers encountered at 7 cancer treatment centers. J Neurosurg. 2024. PMID: 38848602. doi:10.3171/2024.3.JNS232654
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。